Clincosm LogoSign in Get a demo

transarterial chemoembolization

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A New Conception About Individualized Treatment Allocation for

Completed
  • HCC
  • +2 more
  • TACE
  • (no location specified)
Aug 22, 2023

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • +3 more
  • lenvatinib + sindilimab/carrelizumab
  • TACE
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 23, 2022

Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of

Recruiting
  • Circulating Tumor DNA
  • +2 more
  • DNA
  • Rouen, France
    CHU de Rouen
May 23, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization Trial in Guangzhou (TACE-HAIC plus lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial Chemoembolization
  • TACE-HAIC plus lenvatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

Not yet recruiting
  • HCC
  • +3 more
  • (no location specified)
Aug 28, 2021

Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization, Apatinib Trial in Chengdu (DEB-TACE combined with apatinib and

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • +3 more
  • DEB-TACE combined with apatinib and PD-1 antibody
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Apr 4, 2021

Transarterial Chemoembolization, Hepatocellular Carcinoma Trial (cTACE-HAIC)

Unknown status
  • Transarterial Chemoembolization
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 17, 2020

Hepatocellular Carcinoma, Sorafenib, Transarterial Chemoembolization Trial in Guangzhou (TACE+sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • +2 more
  • TACE+sorafenib
  • TACE
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 24, 2019

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Microwave Ablation Trial in China (procedure, device,

Unknown status
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • TACE
  • +3 more
  • Beijing, Beijing, China
  • +9 more
May 6, 2019

Hepatocellular Carcinoma, Transarterial Chemoembolization Trial in Anyang, Chuncheon, Seoul (Intermediate embolization, Complete

Unknown status
  • Hepatocellular Carcinoma
  • Transarterial Chemoembolization
  • Intermediate embolization
  • Complete embolization
  • Anyang, Korea, Republic of
  • +2 more
Aug 29, 2012